We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
High-throughput Screening: Microscale Thermophoresis to Characterize Hits
News

High-throughput Screening: Microscale Thermophoresis to Characterize Hits

High-throughput Screening: Microscale Thermophoresis to Characterize Hits
News

High-throughput Screening: Microscale Thermophoresis to Characterize Hits

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "High-throughput Screening: Microscale Thermophoresis to Characterize Hits"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A new perspective article in the March 2018 issue of SLAS Discovery from the biology group at the European Screening Centre Newhouse details how the European Lead Factory (ELF), a large publicly accessible drug discovery platform, uses microscale thermophoresis (MST) to aid in the prioritization of small molecule hits from high-throughput screening.

MST measures the rate and direction of movement of biomolecules through a temperature gradient, which can change when small molecules bind to them. The authors describe the MST technology, their assay development and screening workflows, lessons learned and compare the success of MST with other common biophysical assay techniques.

Developing the use of such relatively new technologies is critically important to improving the efficiency of drug discovery. According to the authors, most drug discovery professionals have war stories of trying to develop hit compounds only to have experienced crashing disappointment, often at great expense, as it became apparent the compounds were affecting the target protein through some spurious, unproductive and ultimately undevelopable mechanism.

The ELF provides a unique perspective in evaluating the usefulness of MST in avoiding this unpleasant dead-end due to the scale of their activities and the large number and variety of targets that have been worked on.

This article has been republished from materials provided by SLAS. Note: material may have been edited for length and content. For further information, please contact the cited source.

'Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective' can be accessed here.

Advertisement